Radio: Peeling paint, shoddy cleanups among issues at plant making J&J COVID-19 vaccine, FDA says
ovp test
Male shot by female at Shreveport apartment
Class to create biodiverse backyard
Rules for outbursts at Caddo School Board Meeting
maylen
A U.S. plant that was making Johnson & Johnson’s COVID-19 vaccine must fix a long list of problems including peeling paint, shoddy cleanups, and poorly-trained staff to resume operation, according to a highly critical report by the Food and Drug Administration. NewsNation’s Ashley Ketz reports.
